Phenindione

6-(5 H )-Phenanthridinone is an inhibitor of poly(ADP-ribose)polymerase (PARP)-1 activity . The ability of 6-(5 H )-phenanthridinone to potentiate the effect of ionizing radiation on tumour cells was evaluated .

Application Catalyst for conversion of 1,4-alkynediols into pyrroles Catalyst for oxidation of primary alcohols to methyl esters Catalyst for rearrangement of oximes to amides Catalyst for C-C coupling via directed C-H activation Catalyst for enyne

Application Catalyst for hydration of nitriles, isomerization of alkynes,Knoevenagel reactions and conjugate additions, and transferhydrogenation

Application Umicore Precatalysts for Asymmetric and Cross-Coupling Catalysis Catalyst in: Ruthenium-catalyzed hydrogenation Preparation of Walphos-type ferrocenyl-aryl diphosphine ligands Ruthenium-catalyzed synthesis reactions Enantioselective

Application Used for preparation of ultra-high temperature ceramics Reactant in synthesis of hafnium-containing organometallic polymers Additive in alloys Used in coatings

Atto 425 Phalloidin is a novel fluorescent label with a coumarin structure. The dye is intended for application in the area of life science, e.

Phalloidin Atto 488is a hydrophilic fluorescent label with high water solubility. Post coupling to a substrate, the fluorescent label carries a net electrical charge of -1.

Atto 532 is a novel fluorescent label related to the well-known dye Rhodamine 6G. The dye is designed for application in the area of life science, e.

Atto 565 is a novel fluorescent label that belongs to the class of Rhodamine dyes. It shows a strong absorption, high fluorescence quantum yield, high thermal and photostability, and a very little triplet formation.

Atto 594 is a novel fluorescent label belonging to the class of Rhodamine dyes. The dye is designed for application in the area of life science, e.

Phalloidin&#8211Atto 647N is a new fluorescentlabel targeting the red spectral region. Atto 647N is a cationic dye, and postcoupling, it carries a net electrical charge of +1.

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the